May 10, 2023 Keystone Capital Partners, LLCCommon Stock Purchase Agreement • June 5th, 2023 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledJune 5th, 2023 Company Industry
STOCK EXCHANGE AGREEMENTStock Exchange Agreement • June 5th, 2023 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledJune 5th, 2023 Company IndustryThis Stock Purchase Agreement (the “Agreement”) is dated as of June 1, 2023 between Navidea Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), and the stockholder identified on the signature page hereto (the “Stockholder”).